CORGENIX SUBMITS FDA PREMARKET NOTIFICATION OF ASPIRINWORKS TEST KIT

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has submitted a Premarket Notification (510k) to the U.S. Food and Drug Administration (FDA) for the Company's AspirinWorks Test Kit, the Company's newest diagnostic product for cardiovascular disease.
Business Wire